Disclosures for "A Retrospective Analysis of Cannabidiol (CBD) Use in a Concussion Cohort")
-
Dr. Rafie has nothing to disclose.
-
Mr. Rosenbaum has received research support from Region IV Training Center.
-
Dr. Bickart has nothing to disclose.
-
Neil Avinash Bhathela, MD has nothing to disclose.
-
Mr. Chung has nothing to disclose.
-
Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Highmark Interactive. Dr. Giza has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceutical. Dr. Giza has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Lewitt, Hackman, Shapiro, Marshall & Harlan. Dr. Giza has received stock or an ownership interest from Highmark Interactive. The institution of Dr. Giza has received research support from NCAA. The institution of Dr. Giza has received research support from US Department of Defense. The institution of Dr. Giza has received research support from UCLA: Brain Injury Research Center, Steve Tisch BrainSPORT Program, Easton Clinic for Brain Health. Dr. Giza has received publishing royalties from a publication relating to health care.
-
Dr. Choe has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Cases. Dr. Choe has a non-compensated relationship as a Board of Directors with NABIS that is relevant to AAN interests or activities. Dr. Choe has a non-compensated relationship as a Consultant with USA Swimming Concussion Task Force that is relevant to AAN interests or activities.